PLoS ONE (Jan 2018)

Health-related quality of life in patients with autoimmune hepatitis: A questionnaire survey.

  • Atsushi Takahashi,
  • Kei Moriya,
  • Hiromasa Ohira,
  • Teruko Arinaga-Hino,
  • Mikio Zeniya,
  • Takuji Torimura,
  • Masanori Abe,
  • Akinobu Takaki,
  • Jong-Hon Kang,
  • Ayano Inui,
  • Tomoo Fujisawa,
  • Kaname Yoshizawa,
  • Yoshiyuki Suzuki,
  • Nobuhiro Nakamoto,
  • Kazuhiko Koike,
  • Hitoshi Yoshiji,
  • Aya Goto,
  • Atsushi Tanaka,
  • Zobair M Younossi,
  • Hajime Takikawa,
  • Japan AIH Study Group

DOI
https://doi.org/10.1371/journal.pone.0204772
Journal volume & issue
Vol. 13, no. 10
p. e0204772

Abstract

Read online

AIM:Health-related quality of life is impaired in patients with autoimmune hepatitis, but the association between health-related quality of life and patients' backgrounds remains unknown. We assessed health-related quality of life in patients with autoimmune hepatitis and identified factors associated with its impairment. METHODS:We assessed health-related quality of life in patients with autoimmune hepatitis, patients with chronic hepatitis C, and healthy subjects using the Japanese version of the Chronic Liver Disease Questionnaire and the 36-Item Short Form Survey. We compared health-related quality of life in patients with autoimmune hepatitis with that of patients with chronic hepatitis C and healthy subjects. RESULTS:A total of 265 patients with autoimmune hepatitis, 88 patients with chronic hepatitis C, and 97 healthy subjects were enrolled; most patients were women. The median ages of patients were 65, 66, and 57 years, respectively. Of these patients with autoimmune hepatitis, 10.6% and 57.0% had cirrhosis and comorbid diseases, respectively. The overall Chronic Liver Disease Questionnaire scores (5.5 vs. 6.2, P < 0.001) and physical (48.1 vs. 54.2, P < 0.001) and mental (51.8 vs. 55.0, P = 0.004) component summaries of 36-Item Short Form Survey were significantly lower in patients with autoimmune hepatitis than in healthy subjects, and similar to scores in patients with chronic hepatitis C. Having cirrhosis, comorbid diseases, and treatment for autoimmune hepatitis were associated with impaired health-related quality of life among patients with autoimmune hepatitis. In particular, prednisolone use was associated with lower scores on the worry domain of the Chronic Liver Disease Questionnaire. CONCLUSIONS:Patients with autoimmune hepatitis showed impairment in health-related quality of life, which was associated with not only disease progression, but also comorbid diseases and treatment. Ways to improve health-related quality of life should be considered in patients with AIH when disease outcome is not favorable and when using prednisolone.